Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Tighter Blood Pressure Control Is Associated with Lower Incidence of Erectile Dysfunction in Hypertensive Men.

Hsiao W, Bertsch RA, Hung YY, Aaronson DS.

J Sex Med. 2019 Mar;16(3):410-417. doi: 10.1016/j.jsxm.2019.01.011.

PMID:
30846114
2.

AUTHOR REPLY.

Kwan ML, Danforth KN, Aaronson DS, Wagner MD, Williams SG, McMullen CK.

Urology. 2019 Mar;125:229. doi: 10.1016/j.urology.2018.11.023. No abstract available.

PMID:
30798971
3.

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.

Kwan ML, Kushi LH, Danforth KN, Roh JM, Ergas IJ, Lee VS, Cannavale KL, Harrison TN, Contreras R, Loo RK, Aaronson DS, Quesenberry CP, Tritchler D, Ghai NR, Quinn VP, Ambrosone CB, Zhang Y, Tang L.

Cancer Causes Control. 2019 Feb;30(2):187-193. doi: 10.1007/s10552-019-1130-8. Epub 2019 Jan 17.

PMID:
30656539
4.

Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care Systems.

Kwan ML, Leo MC, Danforth KN, Weinmann S, Lee VS, Munneke JR, Bulkley JE, Rosetti MO, Yi DK, Banegas MP, Wagner MD, Williams SG, Aaronson DS, Grant M, Krouse RS, Gilbert SM, McMullen CK.

Urology. 2019 Mar;125:222-229. doi: 10.1016/j.urology.2018.09.037. Epub 2018 Nov 22.

PMID:
30471370
5.

Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use.

Check DK, Aaronson DS, Nielsen ME, Lee VS, Ergas IJ, Roh JM, Kushi LH, Tang L, Kwan ML.

Urology. 2019 Feb;124:107-112. doi: 10.1016/j.urology.2018.10.016. Epub 2018 Oct 23.

PMID:
30359712
6.

The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.

Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R Jr, Loo RK, Aaronson DS, Horwitz RI, Jacobsen SJ.

Urology. 2018 Sep;119:70-78. doi: 10.1016/j.urology.2018.05.033. Epub 2018 Jun 12.

PMID:
29906480
7.

Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.

Taylor KL, Luta G, Hoffman RM, Davis KM, Lobo T, Zhou Y, Leimpeter A, Shan J, Jensen RE, Aaronson DS, Van Den Eeden SK.

Transl Behav Med. 2018 Mar 1;8(2):156-165. doi: 10.1093/tbm/ibx005.

8.

Physicians' perspectives on the informational needs of low-risk prostate cancer patients.

Hagerman CJ, Bellini PG, Davis KM, Hoffman RM, Aaronson DS, Leigh DY, Zinar RE, Penson D, Van Den Eeden S, Taylor KL.

Health Educ Res. 2017 Apr 1;32(2):134-152. doi: 10.1093/her/cyx035.

9.

5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia.

Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R Jr, Loo RK, Aaronson DS, Richert-Boe K, Horwitz RI, Jacobsen SJ.

Mayo Clin Proc. 2016 Dec;91(12):1717-1726. doi: 10.1016/j.mayocp.2016.07.023. Epub 2016 Oct 27.

PMID:
28126151
10.

Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.

Fu AZ, Tsai HT, Haque R, Yood MU, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS, Potosky AL.

J Urol. 2017 Jun;197(6):1448-1454. doi: 10.1016/j.juro.2016.12.086. Epub 2016 Dec 19.

11.

Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management.

Kelly SP, Van Den Eeden SK, Hoffman RM, Aaronson DS, Lobo T, Luta G, Leimpter AD, Shan J, Potosky AL, Taylor KL.

J Urol. 2016 Sep;196(3):734-40. doi: 10.1016/j.juro.2016.04.045. Epub 2016 Apr 14.

12.

Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.

Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Van Den Eeden SK, Cassidy-Bushrow AE, Zhou Y, Keating NL, Smith MR, Aaronson DS, Potosky AL.

World J Urol. 2016 Dec;34(12):1611-1619. Epub 2016 Apr 15.

13.

Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.

Aaronson DS, Redberg RF.

JAMA Intern Med. 2016 Apr;176(4):547-8. doi: 10.1001/jamainternmed.2015.8104. No abstract available.

PMID:
26856746
14.

Surgical care and career opportunities in a changing practice paradigm.

Tepas JJ 3rd, Hughes TG Sr, Aaronson DS, Kesler JL, Buckley RJ, Dippolito AJ, Wall MJ, Merchant NB, Dandridge WC, Sinanan MN, Buchbinder D, Sussman HL, Hayes-Jordan A, Chen JC, Wetstein L, Arbutina DR, Dennehy JC 3rd, Alseidi A, Rege RV, Fink AS, Barney LM, Cloyd DW, Fallat ME, Loeff DS, Behrns KE, Vickers SM.

J Am Coll Surg. 2013 Oct;217(4):711-717.e1. doi: 10.1016/j.jamcollsurg.2013.05.031. No abstract available.

PMID:
24054411
15.
16.

National incidence and outcomes of postoperative urinary retention in the Surgical Care Improvement Project.

Wu AK, Auerbach AD, Aaronson DS.

Am J Surg. 2012 Aug;204(2):167-71. doi: 10.1016/j.amjsurg.2011.11.012. Epub 2012 May 3.

PMID:
22560203
17.

Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come.

Aaronson DS, Odisho AY, Hills N, Cress R, Carroll PR, Dudley RA, Cooperberg MR.

Arch Intern Med. 2012 Feb 13;172(3):280-3. doi: 10.1001/archinternmed.2011.711. No abstract available.

18.

Prediction of hospital acute myocardial infarction and heart failure 30-day mortality rates using publicly reported performance measures.

Aaronson DS, Bardach NS, Lin GA, Chattopadhyay A, Goldman LE, Dudley RA.

J Healthc Qual. 2013 Mar-Apr;35(2):15-23. doi: 10.1111/j.1945-1474.2011.00173.x. Epub 2011 Nov 11.

19.

Safer urethral catheters: how study of catheter balloon pressure and force can guide design.

Wu AK, Blaschko SD, Garcia M, McAninch JW, Aaronson DS.

BJU Int. 2012 Apr;109(7):1110-4. doi: 10.1111/j.1464-410X.2011.10510.x. Epub 2011 Aug 22.

20.

Use of Google Insights for Search to track seasonal and geographic kidney stone incidence in the United States.

Breyer BN, Sen S, Aaronson DS, Stoller ML, Erickson BA, Eisenberg ML.

Urology. 2011 Aug;78(2):267-71. doi: 10.1016/j.urology.2011.01.010. Epub 2011 Apr 3.

21.

National incidence and impact of noninfectious urethral catheter related complications on the Surgical Care Improvement Project.

Aaronson DS, Wu AK, Blaschko SD, McAninch JW, Garcia M.

J Urol. 2011 May;185(5):1756-60. doi: 10.1016/j.juro.2010.12.041. Epub 2011 Mar 21.

PMID:
21420117
22.

Complications rates of non-oncologic urologic procedures in population-based data: a comparison to published series.

Aaronson DS, Erickson BA, Allareddy V, Nelles JL, Konety BR.

Int Braz J Urol. 2010 Sep-Oct;36(5):548-56.

23.

Selective arterial embolization of angiomyolipoma leading to pulmonary hypertension.

Lee F, Aaronson DS, Blaschko S, Barbosa P, Wu AK, Eisenberg M, Erickson BA, McAninch JW.

Can J Urol. 2010 Jun;17(3):5232-5.

PMID:
20566024
24.

U.S. national statistics on penile fracture.

Aaronson DS, Shindel AW.

J Sex Med. 2010 Sep;7(9):3226. doi: 10.1111/j.1743-6109.2010.01879.x. No abstract available.

PMID:
20561163
25.

Squamous cell carcinoma at the site of a Prince Albert's piercing.

Edlin RS, Aaronson DS, Wu AK, Blaschko SD, Yang G, Erickson BA, McAninch JW.

J Sex Med. 2010 Jun;7(6):2280-2283. doi: 10.1111/j.1743-6109.2010.01818.x. Epub 2010 Apr 19.

PMID:
20412425
26.

Advocating for safer use of sexual enhancement products.

Aaronson DS, Shindel AW.

J Sex Med. 2010 Jun;7(6):2285-2287. doi: 10.1111/j.1743-6109.2010.01770.x. Epub 2010 Mar 26. No abstract available.

PMID:
20367765
27.

A novel application of 1H magnetic resonance spectroscopy: non-invasive identification of spermatogenesis in men with non-obstructive azoospermia.

Aaronson DS, Iman R, Walsh TJ, Kurhanewicz J, Turek PJ.

Hum Reprod. 2010 Apr;25(4):847-52. doi: 10.1093/humrep/dep475. Epub 2010 Feb 2.

PMID:
20124393
28.

Evaluation of renal function after major renal injury: correlation with the American Association for the Surgery of Trauma Injury Scale.

Tasian GE, Aaronson DS, McAninch JW.

J Urol. 2010 Jan;183(1):196-200. doi: 10.1016/j.juro.2009.08.149.

PMID:
19913819
29.

Patient decision aids for prostate cancer treatment: a systematic review of the literature.

Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA.

CA Cancer J Clin. 2009 Nov-Dec;59(6):379-90. doi: 10.3322/caac.20039. Epub 2009 Oct 19. Review.

30.

Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.

Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M 3rd, Shinohara K.

BJU Int. 2009 Sep;104(5):600-4. doi: 10.1111/j.1464-410X.2009.08445.x. Epub 2009 Feb 23.

31.

Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief?

Aaronson DS, Walsh TJ, Smith JF, Davies BJ, Hsieh MH, Konety BR.

BJU Int. 2009 Aug;104(4):506-9; discussion 509-10. doi: 10.1111/j.1464-410X.2009.08417.x. Epub 2009 Feb 23. Review.

32.

Is the complication rate of radical cystectomy predictive of the complication rate of other urological procedures?

Fradet V, Allareddy V, Aaronson DS, Konety BR.

J Urol. 2009 Mar;181(3):1054-9; discussion 1059-60. doi: 10.1016/j.juro.2008.11.016. Epub 2009 Jan 16.

PMID:
19150541
33.

Transcorporal artificial urinary sphincter placement for incontinence in high-risk patients after treatment of prostate cancer.

Aaronson DS, Elliott SP, McAninch JW.

Urology. 2008 Oct;72(4):825-7. doi: 10.1016/j.urology.2008.06.065. Epub 2008 Aug 26.

PMID:
18752838
34.

Hydrocele in the pediatric patient: inguinal or scrotal approach?

Wilson JM, Aaronson DS, Schrader R, Baskin LS.

J Urol. 2008 Oct;180(4 Suppl):1724-7; discussion 1727-8. doi: 10.1016/j.juro.2008.03.111. Epub 2008 Aug 21.

PMID:
18721980
35.

Relative contraindication to endoscopic subureteral injection for vesicoureteral reflux: congenital refluxing megaureter with distal aperistaltic segment.

Aaronson DS, Siddiqui SA, Reinberg Y, Baskin LS.

Urology. 2008 Apr;71(4):616-9; discussion 619-20. doi: 10.1016/j.urology.2007.11.086. Epub 2008 Mar 4.

PMID:
18295311
36.

An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells.

Aaronson DS, Muller M, Neves SR, Chung WC, Jayaram G, Iyengar R, Ram PT.

Mol Cell Endocrinol. 2007 May 30;270(1-2):50-6. Epub 2007 Feb 17.

PMID:
17374439
37.

Review of therapy of psoriasis: the prebiologic armamentarium.

Aaronson DS, Lebwohl M.

Dermatol Clin. 2004 Oct;22(4):379-88, viii. Review.

PMID:
15450334
38.

Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization.

Matallanas D, Arozarena I, Berciano MT, Aaronson DS, Pellicer A, Lafarga M, Crespo P.

J Biol Chem. 2003 Feb 14;278(7):4572-81. Epub 2002 Nov 27.

39.

A road map for those who don't know JAK-STAT.

Aaronson DS, Horvath CM.

Science. 2002 May 31;296(5573):1653-5. Review.

PMID:
12040185
40.

The Rho family GTPase Cdc42 regulates the activation of Ras/MAP kinase by the exchange factor Ras-GRF.

Arozarena I, Aaronson DS, Matallanas D, Sanz V, Ajenjo N, Tenbaum SP, Teramoto H, Ighishi T, Zabala JC, Gutkind JS, Crespo P.

J Biol Chem. 2000 Aug 25;275(34):26441-8.

41.

Myeloid leukemia cell growth and differentiation are independent of mitogen-activated protein kinase ERK1/2 activation.

Ajenjo N, Aaronson DS, Ceballos E, Richard C, León J, Crespo P.

J Biol Chem. 2000 Mar 10;275(10):7189-97.

42.

Transforming G protein-coupled receptors block insulin and ras-induced adipocytic differentiation in 3T3-L1 cells: evidence for a PKC and MAP kinase independent pathway.

Crespo P, Font de Mora J, Aaronson DS, Santos E, Gutkind JS.

Biochem Biophys Res Commun. 1998 Apr 17;245(2):554-61.

PMID:
9571194
43.

Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.

Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M, Gutkind JS.

Oncogene. 1996 Aug 1;13(3):455-60.

PMID:
8760286

Supplemental Content

Loading ...
Support Center